14 Jun 2024

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

Presentation of FluoGuide at Life Science Investorkonference Q3 2019


September 20, 2019

FluoGuide A/S ("FluoGuide", ticker FLUO) was presented at the 18 September at the Life Science Investorkonference in Copenhagen, a conference where other life science companies presented their businesses and future plans. The presentation from FluoGuide is now available at FluoGuide’s home page ( and a video will also be made available on FluoGuide’s home page as soon as available. 

FluoGuide will present next time in Stockholm, on 18 November 2019 at the Sedemeradagen.